retatrutide peptide clinical trial results π (Reta) is a synthetic peptide-based drug composed of 39 amino acids. It was developed by Eli Lilly and is being studied extensively as a treatment for obesity and metabolic diseases Lilly's 'triple G' agonist triumphs
Pay in 4 interest-free payments of $5.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 22 - Aug 27
























